Open11.720 | Close11.690 |
Vol / Avg.12.984K / 13.928K | Mkt Cap149.424M |
Day Range11.505 - 11.940 | 52 Wk Range7.580 - 21.500 |
Greenwich LifeSciences Stock (NASDAQ: GLSI) stock price, news, charts, stock research, profile.
Open11.720 | Close11.690 |
Vol / Avg.12.984K / 13.928K | Mkt Cap149.424M |
Day Range11.505 - 11.940 | 52 Wk Range7.580 - 21.500 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.190 | ||||||
REV | 0 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.230 | -0.130 | 0.1000 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-04-10 | HC Wainwright & Co. | Yi Chen | Reiterates | Buy | Lowers | 78.00 | 38.00 |
2021-09-01 | HC Wainwright & Co. | Yi Chen | Initiates Coverage On | Buy | Announces | - | 78.00 |
2021-01-26 | Aegis Capital | Nathan Weinstein | Initiates Coverage On | Buy | Announces | - | 75.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
GLSI | Greenwich LifeSciences | -0.6% | 149.4M |
MOLN | Molecular Partners | 4.05% | 143.5M |
GRPH | Graphite Bio | 1.32% | 133.4M |
LRMR | Larimar Therapeutics | -3.79% | 144.9M |
GNFT | Genfit | 1.56% | 162M |
You can purchase shares of Greenwich LifeSciences (NASDAQ: GLSI) through any online brokerage.
Other companies in Greenwich LifeSciences’s space includes: Molecular Partners (NASDAQ:MOLN), Graphite Bio (NASDAQ:GRPH), Larimar Therapeutics (NASDAQ:LRMR), Genfit (NASDAQ:GNFT) and Monte Rosa Therapeutics (NASDAQ:GLUE).
The latest price target for Greenwich LifeSciences (NASDAQ: GLSI) was reported by HC Wainwright & Co. on Monday, April 10, 2023. The analyst firm set a price target for 38.00 expecting GLSI to rise to within 12 months (a possible 226.74% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Greenwich LifeSciences (NASDAQ: GLSI) is $11.63 last updated December 1, 2023 at 9:48 PM UTC.
There is no dividend information for Greenwich LifeSciences.
Greenwich LifeSciences’s Q3 earnings are confirmed for Thursday, October 19, 2023.
There is no upcoming split for Greenwich LifeSciences.
Greenwich LifeSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.